Skip to content

Lipid Injectable Emulsions (ILE) Do's and Don'ts (T41)

Mar 26 | 2:30PM - 4:00PM

FACULTY & TOPICS

Overview of the 2017 ASPEN ILE Survey With Gap Analysis
Phil Ayers, PharmD, BCNSP, FASHP

Overview and History of ILEs Available in the United States
Jay Mirtallo, MS, RPh, BCNSP, FASHP, FASPEN

Fatty Acid Metabolism and Essential Fatty Acid (EFA) Needs
John Miles, MD

The Use of Alternative ILEs in the Pediatric Population
Kathleen Gura, PharmD, BCNSP

The Utility of Alternative ILEs in the Adult Population
Todd Mattox, PharmD, BCNSP

MODERATOR
Phil Ayers, PharmD, BCNSP, FASHP

LEARNING OBJECTIVES

  1. Summarize the 2017 ASPEN Lipid Survey and Gap Analysis including key findings
  2. Compare and contrast currently available, FDA approved ILEs in the US
  3. Dose ILEs appropriately to achieve adequate EFAs and calories
  4. Solve patient specific cases regarding lipid dosing in both adult and pediatric populations

LEARNING LEVEL: Intermediate
UAN: JA0002345-0000-19-050-L04-P
CE CREDIT: 1.5 hours